Clinical Trial Detail

NCT ID NCT03748641
Title A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Niraparib + Prednisone

Abiraterone + Prednisone

Age Groups: senior adult

No variant requirements are available.